RT Journal Article
SR Electronic
T1 Unmet need of essential treatments for critical illness in Malawi
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.28.21250280
DO 10.1101/2021.01.28.21250280
A1 Raphael Kazidule Kayambankadzanja
A1 Carl Otto Schell
A1 Isaac Mbingwani
A1 Samson Kwazizira Mndolo
A1 Markus Castegren
A1 Tim Baker
YR 2021
UL http://medrxiv.org/content/early/2021/02/01/2021.01.28.21250280.abstract
AB Background Critical illness is common throughout the world and has been the focus of a dramatic increase in attention in the COVID-19 pandemic. Severely deranged vital signs can identify critical illness, are simple to check and treatments that aim to correct derangements are established, basic and low-cost. The aim of the study was to estimate the unmet need of essential treatments for severely deranged vital signs in all adults admitted to hospitals in Malawi.Methods We conducted a cross-sectional study with follow-up of adult hospitalized patients in Malawi. All in-patients aged ≥18 on single days Queen Elizabeth Central Hospital (QECH) and Chiradzulu District Hospital (CDH) were screened.. Patients with hypoxia (oxygen saturation <90%), hypotension (systolic blood pressure <90mmHg) and reduced conscious level (Glasgow Coma Score <9) were included in the study. The a-priori defined essential treatments were oxygen therapy for hypoxia, intravenous fluid for hypotension and an action to protect the airway for reduced consciousness (placing the patient in the lateral position, insertion of an oropharyngeal airway or endo-tracheal tube or manual airway protection).Results Of the 1135 hospital in-patients screened, 45 (4.0%) had hypoxia, 103 (9.1%) had hypotension, and 17 (1.5%) had a reduced conscious level. Of those with hypoxia, 40 were not receiving oxygen (88.9%). Of those with hypotension, 94 were not receiving intravenous fluids (91.3%). Of those with a reduced conscious level, nine were not receiving an action to protect the airway (53.0%).Conclusion There was a large unmet need of essential treatments for critical illness in two hospitals in Malawi.Competing Interest StatementThe authors have declared no competing interest.Funding StatementTB received grants for the study from the Laerdal Foundation, the Association of Anaesthetists of Great Britain and Ireland and Life Support Foundation. Some of the pulse oximeters were donated by the Lifebox Foundation. The funding sources had no role in the design of the study, the collection, analysis and interpretation of data or in writing the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:College of Medicine Research and Ethics Committee (COMREC P.08/16/2007).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData from the research project is still ongoing. However part of it can be made available to researchers upon request.